Coating on Capsules Next Step in Creating Insulin-Producing Factories
One potential cure for type 1 diabetes (T1D) is to replace beta cells destroyed by a person’s own immune system…
Strengthening Type 1 Diabetes Science by Building Careers
Sometimes, the funding that Breakthrough T1D can provide for researchers is exactly the invitation they need to get into the…
Breakthrough T1D Beta Cell Replacement Consortium: Partnerships and Paradigm Shifts
Last week’s Breakthrough T1D Beta Cell Replacement Consortium enabled 57 researchers the chance to collaborate in ways that help move…
Production of Insulin in People with Type 1 Diabetes
Sernova, a clinical-stage regenerative medicine company, has shown in its Breakthrough T1D-funded clinical trial that its cell replacement therapy, the…
Breakthrough T1D Brings Together Leading Experts at Islet Targeting Workshop
Breakthrough T1D is committed is to curing type 1 diabetes (T1D) through beta cell therapies, which is a complicated problem…
One Scientist’s Plan to Regenerate Beta Cells in Boston
Can we internally regenerate and protect beta cells, and therefore find cures for type 1 diabetes (T1D)? One scientist thinks…
ViaCyte Does it Again: Insulin Production in People with T1D
ViaCyte, a beta cell replacement company long supported by Breakthrough T1D, has shown—for the first time ever—that its PEC-Direct therapy…
Breakthrough T1D Launches First Center of Excellence, Aiming to Accelerate Type 1 Diabetes Research
Breakthrough T1D today launched its first Center of Excellence, a new research and funding model aimed at accelerating leading type…
Semma Therapeutics, Backed by the T1D Fund, Acquired by Major Biopharma Company
In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September…
Breakthrough T1D Hosts 3D Bioprinting Workshop for Type 1 Diabetes
Breakthrough T1D is committed to developing cell replacement therapies that will one day offer cures for type 1 diabetes (T1D).…
